|
FAM60A expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62536650805123E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.33066907387547E-16 |
| Normal-vs-Stage2 |
1.264950E-01 |
| Normal-vs-Stage3 |
7.4259000060195E-09 |
| Normal-vs-Stage4 |
7.13350000181023E-08 |
| Stage1-vs-Stage2 |
3.023400E-04 |
| Stage1-vs-Stage3 |
2.698400E-01 |
| Stage1-vs-Stage4 |
9.033000E-01 |
| Stage2-vs-Stage3 |
5.677400E-03 |
| Stage2-vs-Stage4 |
1.620800E-03 |
| Stage3-vs-Stage4 |
4.797600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.11022302462516E-16 |
| Normal-vs-AfricanAmerican |
1.095950E-03 |
| Normal-vs-Asian |
2.01249999998154E-06 |
| Caucasian-vs-AfricanAmerican |
6.224200E-01 |
| Caucasian-vs-Asian |
6.123600E-01 |
| AfricanAmerican-vs-Asian |
4.585600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.65140029323641E-10 |
| Normal-vs-Female |
5.99520433297585E-15 |
| Male-vs-Female |
9.837200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.44089209850063E-16 |
| Normal-vs-Age(41-60Yrs) |
8.42089731278861E-11 |
| Normal-vs-Age(61-80Yrs) |
1.205460E-04 |
| Normal-vs-Age(81-100Yrs) |
1.616360E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.094400E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.758700E-04 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.994400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.204780E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.160400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.797600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.798200E-01 |
| Classical-VS-Follicular |
1.84170456662969E-11 |
| Classical-VS-Other |
2.823200E-01 |
| Classical-VS-Normal |
<1E-12 |
| Tall-VS-Follicular |
8.23790000000768E-05 |
| Tall-VS-Other |
4.135800E-01 |
| Tall-VS-Normal |
1.91289999951216E-07 |
| Follicular-VS-Other |
1.361950E-03 |
| Follicular-VS-Normal |
2.748800E-01 |
| Other-VS-Normal |
3.006400E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.29100000001436E-06 |
| Normal-vs-N1 |
4.0667999967603E-08 |
| N0-vs-N1 |
4.324400E-03 |
|
|
